Header Logo

Steven Gitelis

Concepts (281)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Bone Neoplasms
33
2023
120
7.190
Why?
Sarcoma
15
2023
144
2.530
Why?
Bone Substitutes
9
2017
29
2.090
Why?
Soft Tissue Neoplasms
7
2022
54
1.760
Why?
Bone Transplantation
8
2017
209
1.620
Why?
Giant Cell Tumor of Bone
5
2022
15
1.600
Why?
Sarcoma, Ewing
3
2020
8
1.430
Why?
Calcium Sulfate
6
2012
26
1.070
Why?
Musculoskeletal Diseases
2
2015
46
0.920
Why?
Limb Salvage
5
2023
12
0.900
Why?
Humans
61
2023
28435
0.840
Why?
Neoplasm Recurrence, Local
7
2023
206
0.810
Why?
Retrospective Studies
27
2023
3612
0.800
Why?
Leiomyosarcoma
1
2021
21
0.720
Why?
Adult
24
2022
8107
0.720
Why?
Young Adult
13
2021
2070
0.700
Why?
Adolescent
16
2021
2309
0.700
Why?
Osteosarcoma
8
2021
37
0.690
Why?
Calcium Phosphates
2
2012
23
0.680
Why?
Hip Joint
2
2016
545
0.670
Why?
Child
13
2021
1421
0.660
Why?
Fractures, Bone
2
2012
75
0.640
Why?
Bone Cysts
2
2016
2
0.640
Why?
Synovitis, Pigmented Villonodular
2
2016
3
0.630
Why?
Child, Preschool
9
2021
689
0.630
Why?
Tibia
2
2010
244
0.600
Why?
Treatment Outcome
16
2023
3616
0.560
Why?
Male
26
2021
15292
0.550
Why?
Chondromatosis, Synovial
1
2016
4
0.540
Why?
Arthroplasty, Replacement, Knee
5
2022
625
0.530
Why?
Middle Aged
21
2021
9270
0.530
Why?
Bone Diseases
2
2017
25
0.530
Why?
Internal Fixators
1
2016
36
0.520
Why?
Arthrodesis
2
2014
42
0.520
Why?
Foot
1
2016
44
0.510
Why?
Radiotherapy
1
2016
34
0.510
Why?
Foreign Bodies
1
2016
30
0.510
Why?
Lymphoma, Non-Hodgkin
1
2016
37
0.510
Why?
Acetabulum
3
2016
231
0.500
Why?
Female
23
2021
15728
0.500
Why?
Ultrasonography, Interventional
1
2016
76
0.490
Why?
Radius
2
2014
33
0.480
Why?
Knee Prosthesis
2
2008
222
0.450
Why?
Tobramycin
2
2005
10
0.450
Why?
Survival Rate
5
2021
356
0.430
Why?
Biopsy
6
2023
220
0.410
Why?
Arthralgia
2
2011
125
0.410
Why?
Cell Transformation, Neoplastic
2
2010
31
0.400
Why?
Anti-Bacterial Agents
3
2022
383
0.400
Why?
Chondrosarcoma
4
2023
33
0.380
Why?
Combined Modality Therapy
3
2021
307
0.380
Why?
Prognosis
8
2023
825
0.370
Why?
Proto-Oncogene Proteins c-akt
3
2017
50
0.370
Why?
Histiocytosis, Sinus
1
2011
4
0.370
Why?
Talus
1
2011
13
0.370
Why?
Allografts
4
2021
218
0.360
Why?
Edema
1
2011
25
0.360
Why?
Patellar Ligament
1
2010
42
0.350
Why?
Follow-Up Studies
8
2022
1859
0.350
Why?
Humerus
3
2005
119
0.330
Why?
Lung Neoplasms
2
2015
553
0.330
Why?
Prosthesis Failure
4
2022
536
0.320
Why?
Osteomyelitis
3
2005
20
0.320
Why?
Femur
4
2022
382
0.310
Why?
Debridement
3
2016
102
0.310
Why?
Bone Plates
1
2008
48
0.290
Why?
Reoperation
6
2022
917
0.290
Why?
Neoadjuvant Therapy
5
2022
66
0.280
Why?
Cisplatin
3
2017
52
0.270
Why?
Aged
12
2021
9278
0.270
Why?
Osteogenesis
1
2007
110
0.260
Why?
Arthroplasty, Replacement, Hip
3
2022
821
0.250
Why?
Curettage
3
2022
9
0.240
Why?
Orthopedic Procedures
3
2004
312
0.240
Why?
Disease-Free Survival
3
2021
177
0.240
Why?
Drug Resistance, Neoplasm
3
2017
63
0.240
Why?
Aged, 80 and over
6
2021
4857
0.230
Why?
Immunohistochemistry
4
2011
362
0.230
Why?
Transplantation, Homologous
2
2004
281
0.230
Why?
Margins of Excision
2
2022
31
0.220
Why?
Infant
3
2021
588
0.220
Why?
Pelvic Bones
1
2004
18
0.220
Why?
Lymphatic Metastasis
2
2021
91
0.220
Why?
Joint Instability
1
2008
394
0.220
Why?
Knee Joint
2
2008
746
0.210
Why?
Spinal Neoplasms
1
2023
38
0.210
Why?
Embolization, Therapeutic
1
2023
60
0.210
Why?
Kidney Neoplasms
1
2023
79
0.200
Why?
Injections
2
2016
44
0.200
Why?
Plasma Gases
1
2022
2
0.200
Why?
Prostheses and Implants
2
2015
161
0.200
Why?
Neutrophils
1
2023
110
0.200
Why?
Neoplasm Staging
3
2022
371
0.200
Why?
Tomography, X-Ray Computed
4
2015
730
0.200
Why?
Absorbable Implants
1
2002
27
0.200
Why?
Apoptosis
5
2022
205
0.200
Why?
Sarcoma, Synovial
1
2022
11
0.190
Why?
Vancomycin
1
2002
52
0.190
Why?
Bone Cements
3
2022
90
0.190
Why?
Infant, Newborn
2
2021
655
0.190
Why?
Radiography
5
2015
640
0.190
Why?
Lymphatic Vessels
1
2021
9
0.180
Why?
Myxosarcoma
1
2020
3
0.180
Why?
Hemipelvectomy
1
2020
2
0.180
Why?
Fibrosarcoma
1
2020
9
0.180
Why?
Pelvic Neoplasms
1
2020
4
0.180
Why?
Orthopedics
1
2002
113
0.170
Why?
Receptor, IGF Type 1
2
2017
19
0.170
Why?
Prosthesis-Related Infections
1
2022
186
0.160
Why?
Hip Prosthesis
2
2022
552
0.160
Why?
Cell Line, Tumor
7
2017
249
0.160
Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2016
8
0.160
Why?
Medically Underserved Area
1
2019
15
0.160
Why?
Dogs
4
2007
184
0.160
Why?
Antineoplastic Agents
3
2017
190
0.160
Why?
Chemoradiotherapy
1
2019
61
0.150
Why?
Medical Oncology
1
2019
42
0.150
Why?
Chemotherapy, Adjuvant
2
2010
81
0.150
Why?
Tumor Suppressor Protein p53
2
2016
82
0.150
Why?
Osteoarthritis
1
2022
328
0.150
Why?
Health Services Accessibility
1
2019
111
0.150
Why?
Healthcare Disparities
1
2019
89
0.140
Why?
Receptors, Somatomedin
1
2017
4
0.140
Why?
Protein Kinase Inhibitors
2
2017
50
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
241
0.140
Why?
Imidazoles
1
2017
55
0.140
Why?
Piperazines
1
2017
80
0.130
Why?
Ceramics
1
2016
22
0.130
Why?
Mechanistic Target of Rapamycin Complex 1
1
2016
10
0.130
Why?
Synovectomy
1
2016
5
0.130
Why?
Chondroma
3
2012
5
0.130
Why?
Biocompatible Materials
1
2016
95
0.130
Why?
Child Development
1
2016
75
0.120
Why?
Femoral Neoplasms
1
2015
4
0.120
Why?
Cohort Studies
1
2021
1926
0.120
Why?
Time Factors
3
2022
1491
0.120
Why?
Prosthesis Implantation
1
2015
29
0.120
Why?
Disease Management
1
2016
114
0.120
Why?
Supination
1
2014
20
0.120
Why?
Prosthesis Design
3
2022
498
0.120
Why?
Radiotherapy Dosage
1
2015
117
0.120
Why?
Ossification, Heterotopic
1
2015
36
0.120
Why?
Arthroplasty
1
2016
150
0.120
Why?
Lung
1
2015
170
0.110
Why?
Hand Strength
1
2014
60
0.110
Why?
Cartilage, Articular
2
2016
420
0.110
Why?
Wrist Joint
1
2014
61
0.110
Why?
Drug Implants
2
2005
10
0.110
Why?
Protein Kinases
1
2014
13
0.110
Why?
Risk Factors
2
2022
2408
0.110
Why?
Telomerase
2
2004
9
0.110
Why?
Spinal Fusion
1
2020
465
0.110
Why?
Magnetic Resonance Imaging
2
2011
1143
0.110
Why?
Receptors, Notch
1
2013
1
0.100
Why?
Gene Expression Regulation, Neoplastic
3
2014
113
0.100
Why?
Wnt Proteins
1
2013
22
0.100
Why?
Recovery of Function
2
2012
300
0.100
Why?
Bone Matrix
2
2003
28
0.100
Why?
Fibrous Dysplasia of Bone
1
2012
3
0.100
Why?
Injections, Intralesional
1
2012
32
0.100
Why?
beta Catenin
1
2013
65
0.100
Why?
Bone Regeneration
2
2003
74
0.100
Why?
Diagnosis, Differential
2
2011
373
0.100
Why?
Fluorodeoxyglucose F18
2
2022
37
0.100
Why?
Positron Emission Tomography Computed Tomography
2
2022
34
0.100
Why?
Animals
5
2007
3780
0.090
Why?
Range of Motion, Articular
1
2014
704
0.090
Why?
Ankle
1
2011
24
0.090
Why?
Thoracoscopy
1
2010
23
0.090
Why?
Ilium
1
2010
28
0.090
Why?
Age Factors
2
2019
781
0.080
Why?
Proportional Hazards Models
2
2021
352
0.080
Why?
Predictive Value of Tests
1
2011
492
0.080
Why?
Chicago
1
2012
947
0.080
Why?
Survival Analysis
1
2008
267
0.070
Why?
Compressive Strength
1
2007
23
0.070
Why?
Elasticity
1
2007
31
0.070
Why?
Illinois
1
2008
246
0.070
Why?
Cell Division
3
2022
83
0.070
Why?
Prospective Studies
2
2023
1809
0.070
Why?
Muscle Proteins
1
2006
29
0.070
Why?
Radiation Tolerance
1
2006
6
0.070
Why?
Glycoproteins
1
2006
46
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2006
25
0.070
Why?
Transcription, Genetic
1
2006
106
0.070
Why?
Proteins
1
2006
67
0.070
Why?
Carrier Proteins
1
2006
106
0.060
Why?
Heterocyclic Compounds, 3-Ring
2
2017
13
0.060
Why?
Phosphorylation
2
2016
149
0.060
Why?
Dose-Response Relationship, Drug
1
2005
351
0.060
Why?
Multivariate Analysis
1
2005
331
0.060
Why?
Neoplasm Invasiveness
2
2021
89
0.060
Why?
Blastomycosis
1
2004
21
0.060
Why?
Lower Extremity
1
2023
39
0.050
Why?
Biopsy, Needle
1
2004
108
0.050
Why?
Surgical Flaps
1
2023
51
0.050
Why?
Lymphocyte Count
1
2023
16
0.050
Why?
Bone Demineralization Technique
1
2003
5
0.050
Why?
Tumor Microenvironment
1
2023
16
0.050
Why?
Blood Loss, Surgical
1
2023
59
0.050
Why?
Mutation
2
2021
354
0.050
Why?
Lymphocytes
1
2023
63
0.050
Why?
Preoperative Care
1
2023
125
0.050
Why?
Exoribonucleases
1
2002
1
0.050
Why?
Genes, Tumor Suppressor
1
2002
10
0.050
Why?
Saccharomyces cerevisiae Proteins
1
2002
12
0.050
Why?
Necrosis
1
2022
26
0.050
Why?
Bone Resorption
1
2003
85
0.050
Why?
Replantation
1
2022
10
0.050
Why?
Signal Transduction
2
2016
447
0.050
Why?
Drug Delivery Systems
1
2002
31
0.050
Why?
Transplantation Immunology
1
2002
3
0.050
Why?
Printing, Three-Dimensional
1
2021
9
0.050
Why?
Arthroscopy
1
2011
1086
0.050
Why?
Tissue and Organ Harvesting
1
2002
20
0.050
Why?
Forecasting
1
2002
103
0.050
Why?
Time-to-Treatment
1
2022
35
0.050
Why?
High-Throughput Nucleotide Sequencing
1
2021
47
0.050
Why?
Radiopharmaceuticals
1
2022
53
0.050
Why?
Positron-Emission Tomography
1
2022
89
0.050
Why?
Risk Assessment
1
2004
677
0.050
Why?
SEER Program
1
2021
41
0.040
Why?
Neoplasm Grading
1
2021
52
0.040
Why?
Cartilage
1
2002
102
0.040
Why?
DNA Damage
2
2014
28
0.040
Why?
Chronic Disease
1
2002
441
0.040
Why?
Tendons
1
2002
224
0.040
Why?
Biomechanical Phenomena
1
2002
645
0.040
Why?
Tumor Cells, Cultured
3
2004
119
0.040
Why?
Mesna
1
2019
3
0.040
Why?
Enzyme Activation
2
2014
120
0.040
Why?
Ifosfamide
1
2019
13
0.040
Why?
Organ Sparing Treatments
1
2019
11
0.040
Why?
Leg
1
2019
52
0.040
Why?
Doxorubicin
1
2019
54
0.040
Why?
Arm
1
2019
84
0.040
Why?
Pyrazines
1
2017
10
0.040
Why?
Drug Synergism
1
2017
40
0.040
Why?
Receptor Cross-Talk
1
2016
6
0.030
Why?
Kaplan-Meier Estimate
1
2015
179
0.030
Why?
Checkpoint Kinase 1
1
2014
5
0.030
Why?
Cell Cycle Checkpoints
1
2014
5
0.030
Why?
RNA Interference
1
2014
36
0.030
Why?
Gene Knockdown Techniques
1
2014
45
0.030
Why?
RNA, Small Interfering
1
2014
79
0.030
Why?
Hedgehog Proteins
1
2013
8
0.030
Why?
Culture Techniques
1
1992
17
0.020
Why?
Extracellular Matrix Proteins
1
1992
46
0.020
Why?
Proteoglycans
1
1992
132
0.020
Why?
Acridine Orange
1
2006
1
0.020
Why?
Radiation-Sensitizing Agents
1
2006
5
0.020
Why?
Intracellular Signaling Peptides and Proteins
1
2006
53
0.020
Why?
Gamma Rays
1
2006
17
0.020
Why?
Adaptor Proteins, Signal Transducing
1
2006
65
0.020
Why?
Down-Regulation
1
2006
102
0.020
Why?
Cell Survival
1
2006
120
0.020
Why?
Manubrium
1
2004
2
0.010
Why?
Sternoclavicular Joint
1
2004
6
0.010
Why?
Chondrocytes
1
2004
155
0.010
Why?
Models, Animal
1
2003
115
0.010
Why?
DNA, Complementary
1
2002
27
0.010
Why?
Microscopy, Phase-Contrast
1
2002
5
0.010
Why?
Telomere
1
2002
7
0.010
Why?
Biomarkers, Tumor
1
2004
202
0.010
Why?
DNA Mutational Analysis
1
2002
59
0.010
Why?
Base Sequence
1
2002
107
0.010
Why?
DNA-Binding Proteins
1
2004
274
0.010
Why?
RNA, Messenger
1
2002
308
0.010
Why?
Disease Models, Animal
1
2003
619
0.010
Why?
Sepharose
1
1992
4
0.010
Why?
Hexuronic Acids
1
1992
6
0.010
Why?
Glucuronic Acid
1
1992
6
0.010
Why?
Alginates
1
1992
7
0.010
Why?
Keratan Sulfate
1
1992
15
0.010
Why?
Gels
1
1992
13
0.010
Why?
Lectins, C-Type
1
1992
46
0.010
Why?
Microspheres
1
1992
24
0.010
Why?
Cattle
1
1992
127
0.010
Why?
Aggrecans
1
1992
54
0.010
Why?
Extracellular Matrix
1
1992
51
0.010
Why?
Cells, Cultured
1
1992
539
0.010
Why?
Gitelis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (281)
Explore
_
Co-Authors (26)
Explore
_
Similar People (60)
Explore
_
Physical Neighbors
_